Rentokil Initial (RTO) Equity Average (2022 - 2024)
Historic Equity Average for Rentokil Initial (RTO) over the last 3 years, with Q4 2024 value amounting to $5.3 billion.
- Rentokil Initial's Equity Average rose 660.75% to $5.3 billion in Q4 2024 from the same period last year, while for Dec 2024 it was $5.3 billion, marking a year-over-year increase of 660.75%. This contributed to the annual value of $5.3 billion for FY2024, which is 628.7% up from last year.
- As of Q4 2024, Rentokil Initial's Equity Average stood at $5.3 billion, which was up 660.75% from $5.2 billion recorded in Q2 2024.
- In the past 5 years, Rentokil Initial's Equity Average ranged from a high of $5.3 billion in Q4 2024 and a low of $2.0 billion during Q2 2022
- For the 3-year period, Rentokil Initial's Equity Average averaged around $4.3 billion, with its median value being $4.9 billion (2023).
- Its Equity Average has fluctuated over the past 5 years, first surged by 14922.91% in 2023, then surged by 592.34% in 2024.
- Over the past 3 years, Rentokil Initial's Equity Average (Quarter) stood at $3.5 billion in 2022, then soared by 42.83% to $5.0 billion in 2023, then rose by 6.61% to $5.3 billion in 2024.
- Its last three reported values are $5.3 billion in Q4 2024, $5.2 billion for Q2 2024, and $5.0 billion during Q4 2023.